Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
Amgen Australia was established in 1991. The corporate headquarters are located in Sydney. Amgen Australia employs over 160 people and currently markets eleven products for the treatment of cancer, kidney disease, bone disease and other serious illnesses.
Amgen Australia is amongst the highest contributing countries to Amgen’s global clinical trial activity and invests approximately $30-35 million in local research and development annually.
At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us.
Founded in 1980, Amgen has grown to be one of the world's leading independent biotechnology companies.
Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives.
As one of the early pioneers of the biotech industry, Amgen's innovative and inspirational leadership is a core part of our social architecture.
At Amgen, we are relentless in applying the highest ethical standards to everything we do.
For more than 35 years, Amgen has been unlocking the potential of biology for patients.